QuantRx Biomedical Corp. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$393.48 K |
Shares Outstanding |
78.7 M |
Public Float |
63.94 M |
Address |
10190 SW 90th Avenue Tualatin Oregon 97123 United States |
Employees | - |
Website | http://quantrx.com/Overview.htm |
Updated | 07/08/2019 |
QuantRx Biomedical Corp. engages in the development and commercializing of patented miniform pads (PAD) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and medical needs. Its platforms include inSync(R), Unique(TM), PadKit(R), and OEM branded over-the-counter and laboratory testing products. The company was founded on December 5, 1986 and is headquartered in Tualatin, OR. |